2016

• Nalesnik, N, Tracy, DK, Joyce, D, Patel, S, Rodzinka-Pasko, J, Dolan, H, Hodsoll, J, Collier, T, Rothwell, J & Shergill, SS2016, 'Stimulating cognition in schizophrenia: A controlled pilot study of the effects of prefrontal transcranial direct current stimulation upon memory and learning' Brain Stimulation. DOI: 10.1016/j.brs.2016.12.013

• Vanes, LD, White, TP, Wigton, RL, Joyce, D, Collier, T & Shergill, SS 2016, 'Reduced susceptibility to the sound-induced flash fusion illusion in schizophrenia' Psychiatry Research, vol 245, pp. 58-65. DOI: 10.1016/j.psychres.2016.08.016

• Lally, J, Ajnakina, O, Di Forti, M, Trotta, A, Demjaha, A, Kolliakou, A, Mondelli, V, Reis Marques, T, Pariante, C, Dazzan, P, Shergill, SS, Howes, OD, David, AS, MacCabe, JH, Gaughran, F & Murray, RM 2016, 'Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses' Psychological Medicine, vol 46, no. 15, pp. 3231-3240. DOI: 10.1017/S0033291716002014

• Mallas, E-J., Carletti, F., Chaddock, C. A., Shergill, S., Woolley, J., Picchioni, M. M., ... Prata, D. P. (2016). The impact of CACNA1C gene, and its epistasis with ZNF804A, on white matter microstructure in health, schizophrenia and bipolar disorder. Genes, Brain and Behavior. 10.1111/gbb.12355

• Lage, C., Wiles, K., Shergill, S., & Tracy, D. K. (2016). A systematic review of the effects of low-frequency repetitive transcranial magnetic stimulation on cognition. Journal of neural transmission (Vienna, Austria : 1996), 1-12. 10.1007/s00702-016-1592-8

• Vanes, L. D., White, T. P., Wigton, R. L., Joyce, D., Collier, T., & Shergill, S. S. (2016). Reduced susceptibility to the sound-induced flash fusion illusion in schizophrenia. Psychiatry Research, 245, 58-65. 10.1016/j.psychres.2016.08.016

• Gee, S. H., Shergill, S. S., & Taylor, D. M. (2016). Factors associated with changes in hospitalisation in patients prescribed clozapine. Journal of psychopharmacology (Oxford, England), 30(8), 819-825. 10.1177/0269881116642745

• Martinelli, C., Rigoli, F., & Shergill, S. S. (2016). Aberrant force processing in schizophrenia. Schizophrenia Bulletin.

• Rigoli, F., Friston, K. J., Martinelli, C., Selakovic, M., Shergill, S. S., & Dolan, R. J. (2016). A Bayesian model of context-sensitive value attribution. Elife. 10.7554/eLife.16127

• Lee, J-S., Mathews, A., Shergill, S., & Yiend, J. (2016). Magnitude of negative interpretation bias depends on severity of depression. Behaviour Research and Therapy. 10.1016/j.brat.2016.05.007

• Fett, A. K. J., Shergill, S. S., Korver-Nieberg, N., Yakub, F., Gromann, P. M., & Krabbendam, L. (2016). Learning to trust: Trust and attachment in early psychosis. Psychological Medicine, 46(7), 1437-1447. 10.1017/S0033291716000015

• Kanaan, R. A., Allin, M., Picchioni, M. M., Shergill, S. S., & McGuire, P. K. (2016). White matter microstructural organization is higher with age in adult superior cerebellar peduncles. Frontiers in aging neuroscience, 8(APR), [71]. 10.3389/fnagi.2016.00071

• Dyck, M. S., Mathiak, K. A., Bergert, S., Sarkheil, P., Koush, Y., Alawi, E. M., ... Mathiak, K. (2016). Targeting treatment-resistant auditory verbal hallucinations in schizophrenia with fMRI-based neurofeedback - exploring different cases of schizophrenia. Frontiers in psychiatry / Frontiers Research Foundation, 7(MAR), [37]. 10.3389/fpsyt.2016.00037

• Mallas, E-J., Carletti, F., Chaddock, C. A., Woolley, J., Picchioni, M., Shergill, S. S., ... Prata, D. P. (2016). Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder. PeerJ, 4, [e1570]. 10.7717/peerj.1570

• White, T., Wigton, R., Joyce, D. W., Collier, T., Fornito, A., & Shergill, S. S. (2016). Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia. Neuropsychopharmacology, 41, 1274–1285. 10.1038/npp.2015.277

• Tracy, D. K., Smallcombe, N., Tiwana, F., Fosbraey, J., Sendt, K-V., & Shergill, S. (2016). The glutamate mGluR5 receptor as a pharmacological target to enhance cognitive function: emerging evidence from psychosis models. In F. López-Muñoz, V. Srinivasan, D. De Berardis, C. Álamo, & T. A. Kato (Eds.), Melatonin, neuroprotective agents and antidepressant therapy.. Berlin: Springer.